DU 145
Export
prostate carcinoma cell line derived from metastatic site of brain, epithelial like
Cell Type:
Prostate Epith.
Tissue Origin:
brain
Species:
human
Research Area:
Cancer Research/Cell Biology
Neurobiology
Cell Characteristics:
Adherent
Transfection Information
Lonza Optimized Protocol
Optimization Guideline
Filter:
Any Substrate
Any Platform
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy
to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol
Kit
Program
Cells
Efficiency
Viable Cells
Substrate
Format
Platform
SE
CA-137
1e6
86-94%
63-121%
Plasmid (general)
2 µg
100 µl
4D X-Unit
SE
CA-137
2e5
84-94%
85-87%
Plasmid (general)
400 ng
20 µl
4D X-Unit
L
A-023
1e6
44-50%
87-91%
Plasmid (general)
2 µg
100 µl
I/II/2b
Citations
Histone Deacetylase Inhibitors Sensitize Prostate Cancer Cells to Agents that Produce DNA Double-Strand Breaks by Targeting Ku70 Acetylation
Categories:
Transfection
Authors:
Chen CS, Wang YC, Yang HC, Huang PH, Kulp SK, Yang CC, Lu YS, Matsuyama S, Chen CY, Chen CS
In:
Cancer Res (2007) 67(11): 5318-27
Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of prostate carcinogenesis
Categories:
Transfection
Authors:
Park C, Lee I, Kang WK
In:
Mol Cancer Ther (2006) 5(12): 3191-6
The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines
Categories:
Live Cell Imaging
Authors:
Orellana-Serradell O1, Herrera D1, Castellon EA1, Contreras HR1.
In:
Asian J Androl () 3: 294-299